DGXQuest Diagnostics
Price
+28%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality strong, no red flags, price roughly fair, growth steady, the market undecided.
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians, and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.
In the company’s own words · 10-K filed Feb 26, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Quest Diagnostics (DGX) reported revenue of $3.04B in Q2 2026 (quarter ended Jun 30, 2026), up 10% from the same quarter a year earlier. That came with a gross margin of 34% and net income of $320M (11% of revenue). For the full year FY2025, revenue was $11.0B (+12% year on year) and net income $992M. Its largest segment in Q2 2026 was Diagnostic Information Services Business at $2.98B, 98% of the disclosed total, well ahead of All Other at 2.1%. The next results filing is expected around Oct 20, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 6, 2026On October 6, 2026, Quest Diagnostics Incorporated (the “Company”) announced that Catherine T. Doherty will retire in July 2027.Director or officer change · Form 8-K
- Jul 23, 2026Quest Diagnostics Reports Second Quarter 2026 Financial Results;.Earnings release · press release
- May 8, 2026On May 6, 2026, Quest Diagnostics Incorporated (the “Company”) issued $500,000,000 aggregate principal amount of 5.000% senior notes due 2036 (the “Notes”)Material agreement entered · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $3.04BThe company’s own SEC segment disclosure.
- Diagnostic Information Services Business$2.98B98%
- All Other$65.0M2%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Diagnostics & Research
The closest names by size in the same industry